Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Enhancement of Hematopoietic Cells

  • Read more about Enhancement of Hematopoietic Cells
Patent Cooperation Treaty
PCT/US98/000887
Filed on 1998-01-20

Method of Evaluating Chemotherapeutic Agents in Vivo

  • Read more about Method of Evaluating Chemotherapeutic Agents in Vivo
Patent Cooperation Treaty
PCT/US1994/004443
Filed on 1994-04-21

Substituted Benzimidazoles, as Substituted Benzimidazoles as Non-Nucleoside Inhibitors of Reverse Trancriptase

  • Read more about Substituted Benzimidazoles, as Substituted Benzimidazoles as Non-Nucleoside Inhibitors of Reverse Trancriptase
US Patent 6,369,235
Filed on 2000-02-01

SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS

  • Read more about SELF-ASSEMBLING RECOMBINANT PAPILLOMAVIRUS CAPSID PROTEINS
Patent Cooperation Treaty
PCT/US1993/008342
Filed on 1993-09-03

PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR HEPATITIS C VIRUS IN A MAMMAL

  • Read more about PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR HEPATITIS C VIRUS IN A MAMMAL
Patent Cooperation Treaty
PCT/US1993/005434
Filed on 1993-06-10

AUTOMATED PEPTIDE DESIGN AND SYNTHESIS

  • Read more about AUTOMATED PEPTIDE DESIGN AND SYNTHESIS
Patent Cooperation Treaty
PCT/US90/004725
Filed on 1990-08-21

Demonstration that Page 1 Gene is Specifically Expressed in Prostate, Uterus and Cancers Derived From Them

  • Read more about Demonstration that Page 1 Gene is Specifically Expressed in Prostate, Uterus and Cancers Derived From Them
Patent Cooperation Treaty
PCT/US1999/020046
Filed on 1999-08-31

Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same

  • Read more about Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same
Patent Cooperation Treaty
PCT/US97/02186
Filed on 1997-02-06

Cyanovirin Conjugates and Matrix-Anchored Cyanovirin and Related Compositions and Methods of Use

  • Read more about Cyanovirin Conjugates and Matrix-Anchored Cyanovirin and Related Compositions and Methods of Use
US Patent 6,428,790
Filed on 1999-10-12

METHODS FOR PREDICTING THE EFFICACY OF A CHEMOTHERAPEUTIC REGIMEN FOR GASTROINTESTINAL CANCERS USING ANTIBODIES SPECIFIC FOR THYMIDYLATE...

  • Read more about METHODS FOR PREDICTING THE EFFICACY OF A CHEMOTHERAPEUTIC REGIMEN FOR GASTROINTESTINAL CANCERS USING ANTIBODIES SPECIFIC FOR THYMIDYLATE...
US Application 09/351,732
Filed on 1999-07-08

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1518
  • Page 1519
  • Page 1520
  • Page 1521
  • Page 1522
  • Page 1523
  • Page 1524
  • Page 1525
  • Page 1526
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health